MAP2K7 and plasma cell myeloma: In the study of relevance of JunB in multiple myeloma (MM), IL-6 may trigger the expression of JunB and the activation of MEK/ERK or NFKB is responsible for the induction of JunB expression and AP-1 transcriptional activity [11].